Autolus Therapeutics Plc (AUTL)
1.88
-0.08
(-4.08%)
USD |
NASDAQ |
Sep 11, 16:00
1.885
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Max Drawdown (5Y) : 96.58% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 96.58% |
| July 31, 2026 | 96.58% |
| June 30, 2026 | 96.58% |
| May 31, 2026 | 96.58% |
| April 30, 2026 | 96.58% |
| March 31, 2026 | 96.58% |
| February 28, 2026 | 96.58% |
| January 31, 2026 | 96.58% |
| December 31, 2025 | 96.58% |
| November 30, 2025 | 96.58% |
| October 31, 2025 | 96.58% |
| September 30, 2025 | 96.58% |
| August 31, 2025 | 96.58% |
| July 31, 2025 | 96.58% |
| June 30, 2025 | 96.58% |
| May 31, 2025 | 96.58% |
| April 30, 2025 | 96.58% |
| March 31, 2025 | 96.58% |
| February 28, 2025 | 96.58% |
| January 31, 2025 | 96.58% |
| December 31, 2024 | 96.58% |
| November 30, 2024 | 96.58% |
| October 31, 2024 | 96.58% |
| September 30, 2024 | 96.58% |
| August 31, 2024 | 96.58% |
| Date | Value |
|---|---|
| July 31, 2024 | 96.58% |
| June 30, 2024 | 96.58% |
| May 31, 2024 | 96.58% |
| April 30, 2024 | 96.58% |
| March 31, 2024 | 96.58% |
| February 29, 2024 | 96.58% |
| January 31, 2024 | 96.58% |
| December 31, 2023 | 96.58% |
| November 30, 2023 | 96.58% |
| October 31, 2023 | 96.58% |
| September 30, 2023 | 96.58% |
| August 31, 2023 | 96.58% |
| July 31, 2023 | 96.58% |
| June 30, 2023 | 96.58% |
| May 31, 2023 | 96.58% |
| April 30, 2023 | 96.58% |
| March 31, 2023 | 96.38% |
| February 28, 2023 | 96.38% |
| January 31, 2023 | 96.38% |
| December 31, 2022 | 96.38% |
| November 30, 2022 | 95.83% |
| October 31, 2022 | 95.75% |
| September 30, 2022 | 95.75% |
| August 31, 2022 | 95.75% |
| July 31, 2022 | 95.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bicycle Therapeutics Plc | 93.69% |
| Biodexa Pharmaceuticals Plc | 100.0% |
| argenx SE | 38.20% |
| Mereo BioPharma Group Plc | 95.13% |
| Evaxion AS | 99.79% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.07 |
| Beta (5Y) | 2.100 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 83.82% |
| Historical Sharpe Ratio (5Y) | -0.2748 |
| Historical Sortino (5Y) | -0.6282 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.52% |